RPS Diagnostics - InflammaDry and AdenoPlus diagnostic businesses
Sarasota
About RPS Diagnostics - InflammaDry and AdenoPlus diagnostic businesses
RPS Diagnostics - InflammaDry and AdenoPlus diagnostic businesses are rapid, lateral-flow based, POC products for the detection of infectious and inflammatory diseases and conditions of the eye. InflammaDry is the only test that detects elevated levels of MMP-9, a key inflammatory marker for dry eye. AdenoPlus is a test on market today that differentiates between a viral and bacterial infection of acute conjunctivitis (pink eye). Both products utilize innovative patented technology, are also CE marked, FDA-cleared, CLIA-waived, and complement Quidel's existing rapid diagnostic testing solutions. Manufacturing for both products will be transferred to Quidel's San Diego facility in the near term.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
Canonical: https://fsome.com/organization/rps-diagnostics-inflammadry-and-adenoplus-diagnostic-businesses-673576 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.